9760291

Source:http://linkedlifedata.com/resource/pubmed/id/9760291

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0026565, umls-concept:C0030705, umls-concept:C0151699, umls-concept:C0681842
pubmed:issue	14
pubmed:dateCreated	1998-10-28
pubmed:abstractText	Limited information exists on risk factors for mortality after thrombolysis-related intracranial hemorrhage. We wished to determine the characteristics associated with 30-day mortality after thrombolysis-related intracranial hemorrhage. METHODS and
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0147763
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Heparin, http://linkedlifedata.com/resource/pubmed/chemical/Streptokinase, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0009-7322
pubmed:author	pubmed-author:CaliffR MRM, pubmed-author:GoreJ MJM, pubmed-author:GrangerC BCB, pubmed-author:GreerC HCH, pubmed-author:KoudstaalPP, pubmed-author:LongstrethW TWTJr, pubmed-author:MahaffeyK WKW, pubmed-author:SilaC ACA, pubmed-author:SimoonsM LML, pubmed-author:SloanM AMA, pubmed-author:TopolE JEJ, pubmed-author:WeaverW DWD, pubmed-author:WhiteH DHD
pubmed:issnType	Print
pubmed:day	6
pubmed:volume	98
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1376-82
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:9760291-Aged, pubmed-meshheading:9760291-Anticoagulants, pubmed-meshheading:9760291-Cerebral Hemorrhage, pubmed-meshheading:9760291-Child, pubmed-meshheading:9760291-Drug Therapy, Combination, pubmed-meshheading:9760291-Encephalocele, pubmed-meshheading:9760291-Female, pubmed-meshheading:9760291-Fibrinolytic Agents, pubmed-meshheading:9760291-Glasgow Coma Scale, pubmed-meshheading:9760291-Heparin, pubmed-meshheading:9760291-Humans, pubmed-meshheading:9760291-Hydrocephalus, pubmed-meshheading:9760291-Male, pubmed-meshheading:9760291-Middle Aged, pubmed-meshheading:9760291-Models, Theoretical, pubmed-meshheading:9760291-Multivariate Analysis, pubmed-meshheading:9760291-Myocardial Infarction, pubmed-meshheading:9760291-Risk Factors, pubmed-meshheading:9760291-Single-Blind Method, pubmed-meshheading:9760291-Streptokinase, pubmed-meshheading:9760291-Thrombolytic Therapy, pubmed-meshheading:9760291-Time Factors, pubmed-meshheading:9760291-Tissue Plasminogen Activator, pubmed-meshheading:9760291-Treatment Outcome
pubmed:year	1998
pubmed:articleTitle	Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage.
pubmed:affiliation	University of Maryland Medical System, Baltimore, MD, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study